BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33192992)

  • 1. Emerging Roles of microRNAs as Biomarkers and Therapeutic Targets for Diabetic Neuropathy.
    Fan B; Chopp M; Zhang ZG; Liu XS
    Front Neurol; 2020; 11():558758. PubMed ID: 33192992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical potential of circulating microRNAs in obesity.
    Ji C; Guo X
    Nat Rev Endocrinol; 2019 Dec; 15(12):731-743. PubMed ID: 31611648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circulating exosomal microRNAs related to albuminuria in patients with diabetic nephropathy.
    Kim H; Bae YU; Jeon JS; Noh H; Park HK; Byun DW; Han DC; Ryu S; Kwon SH
    J Transl Med; 2019 Jul; 17(1):236. PubMed ID: 31331349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as Therapeutic Targets in Lung Disease: Prospects and Challenges.
    Sato T; Baskoro H; Rennard SI; Seyama K; Takahashi K
    Chronic Obstr Pulm Dis; 2015 Dec; 3(1):382-388. PubMed ID: 28848860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy.
    Zhou H; Ni WJ; Meng XM; Tang LQ
    Front Cell Dev Biol; 2020; 8():618536. PubMed ID: 33569382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intercellular communication by extracellular vesicles and their microRNAs in asthma.
    Fujita Y; Yoshioka Y; Ito S; Araya J; Kuwano K; Ochiya T
    Clin Ther; 2014 Jun; 36(6):873-81. PubMed ID: 24909737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.
    Ghai V; Wu X; Bheda-Malge A; Argyropoulos CP; Bernardo JF; Orchard T; Galas D; Wang K
    Kidney Int Rep; 2018 May; 3(3):555-572. PubMed ID: 29854963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Fluitt MB; Mohit N; Gambhir KK; Nunlee-Bland G
    J Diabetes Res; 2022; 2022():5126968. PubMed ID: 35237694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.
    Mirra P; Raciti GA; Nigro C; Fiory F; D'Esposito V; Formisano P; Beguinot F; Miele C
    Epigenomics; 2015; 7(4):653-67. PubMed ID: 26111035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Diabetic Nephropathy: Novel Insights from microRNAs.
    Lanzaro F; Barlabà A; De Nigris A; Di Domenico F; Verde V; Miraglia Del Giudice E; Di Sessa A
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.
    Negi S; Rutman AK; Paraskevas S
    Curr Diab Rep; 2019 Jul; 19(9):69. PubMed ID: 31367976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory roles and therapeutic potential of microRNA in sarcoma.
    Lim HJ; Yang JL
    Crit Rev Oncol Hematol; 2016 Jan; 97():118-30. PubMed ID: 26318097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
    Novak J; Souček M
    Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of extracellular vesicle microRNAs in cancer biology.
    Takahashi RU; Prieto-Vila M; Hironaka A; Ochiya T
    Clin Chem Lab Med; 2017 May; 55(5):648-656. PubMed ID: 28231055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.